← Back

Letrozole

Aromatase inhibitor
Tablet2.5 mg169 brands · 141 makers
Letrozole is an aromatase inhibitor. Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. Letrozole is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Immunomodulators, Antineoplastic and Medicines used in Palliative Care.
Generic nameletrozole
Therapeutic classImmunomodulators, Antineoplastic and Medicines used in Palliative Care > 8.2.4 Hormones and antihormones (complementary list)
Form & strength (NLEM)Tablet: 2.5 mg
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

From the U.S. FDA-approved label for Letrozole. Full label: DailyMed.

Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. 1.2 Extended Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.

From the U.S. FDA-approved label for Letrozole. Full label: DailyMed.

Letrozole tablets are taken orally without regard to meals: Recommended dose: 2.5.mg once daily Patients with cirrhosis or severe hepatic impairment: 2.5 mg every other day 2.1 Recommended Dose The recommended dose of letrozole tablet is one 2.5 mg tablet administered once a day, without regard to meals. 2.2 Use in Adjuvant Treatment of Early Breast Cancer In the adjuvant setting, the optimal duration of treatment with letrozole is unknown. In both the adjuvant study and the post approval adjuvant study, median treatment duration was 5 years.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Pregnancy: Letrozole can cause fetal harm. Pregnancy: Letrozole can cause fetal harm. Known hypersensitivity to the active substance, or to any of the excipients. Known hypersensitivity to the active substance, or to any of the excipients. Pregnancy Known hypersensitivity to the active substance, or to any of the excipients

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Decreases in bone mineral density may occur. Consider bone mineral density monitoring Increases in total cholesterol may occur. Consider cholesterol monitoring. Fatigue, dizziness and somnolence may occur. Exercise caution when operating machinery Embryo-Fetal Toxicity: Can cause fetal harm when administered to pregnant women. Obtain a pregnancy test in females of reproductive potential. Advise females of reproductive potential to use effective contraception 5.1 Bone Effects Use of letrozole may cause decreases in bone mineral density (BMD). Consideration should be given to monitoring BMD.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are discussed in greater detail in other sections of the labeling. Bone effects Increases in cholesterol Fatigue and Dizziness The most common adverse reactions (greater than 20%) were hot flashes, arthralgia; flushing, asthenia, edema, arthralgia, headache, dizziness, hypercholesterolemia, sweating increased, bone pain and musculoskeletal.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

169 products from 141 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Fempro 2.5mg TabletLetrozole (2.5mg)Cipla Ltd.
Lerozol 2.5 mg TabletLetrozole (2.5 mg)Square Pharmaceuticals Ltd.
Letoripe 2.5mg TabletLetrozole (2.5mg)RENATA LIMITED
Mamazol 2.5mg TabletLetrozole (2.5mg)Khandelwal Laboratories Pvt Ltd
Trozet 2.5mg TabletLetrozole (2.5mg)Fresenius Kabi pharmaceuticals
Anzen 2.5mg TabletLetrozole (2.5mg)Sanzyme Ltdstrip of 10 tablets
Apletro 5mg TabletLetrozole (5mg)Apkavit Lifesciencesstrip of 5 tablets
Arobit 2.5mg TabletLetrozole (2.5mg)Eskag Pharma Pvt Ltdstrip of 10 tablets
Arolet TabletLetrozole (NA)Estragen Pharmastrip of 10 tablets
Arvilet 2.5mg TabletLetrozole (2.5mg)Arvincare Pharmastrip of 10 tablets
Bd Letro 2.5mg TabletLetrozole (2.5mg)BDR Pharmaceuticals Internationals Pvtstrip of 10 tablets
Beelet 2.5mg TabletLetrozole (2.5mg)Biocin Genetics & Pharmastrip of 5 tablets
Bestova L 2.5mg TabletLetrozole (2.5mg)Akumentis Healthcare Ltdstrip of 10 tablets
Brelet 2.5mg TabletLetrozole (2.5mg)East West Pharmastrip of 5 tablets
Briteova 2.5 TabletLetrozole (2.5mg)Medgrow Health Carestrip of 5 tablets
Briteova 5 TabletLetrozole (5mg)Medgrow Health Carestrip of 5 tablets
Brylet TabletLetrozole (2.5mg)Bryson Pharmaceutical Llpstrip of 10 tablets
Caditraz 2.5mg TabletLetrozole (2.5mg)Cadila Pharmaceuticals Ltdstrip of 10 tablets
Canctroz 2.5mg TabletLetrozole (2.5mg)Lamiaceae Healthcarestrip of 10 tablets
CCQ-L TabletLetrozole (2.5mg)TTK Healthcare Ltdstrip of 5 tablets
Celofem 2.5mg TabletLetrozole (2.5mg)Celon Laboratories Ltdstrip of 10 tablets
Ceolet 2.5mg TabletLetrozole (2.5mg)Cieo Remediestrip of 5 tablets
Chemlet 2.5mg TabletLetrozole (2.5mg)Neon Laboratories Ltdstrip of 10 tablets
Clomipure-L TabletLetrozole (2.5mg)Akumentis Healthcare Ltdstrip of 5 tablets
Clomset L TabletLetrozole (NA)Dahlia Pharmaceutical Pvt Ltdstrip of 5 tablets
Concilet TabletLetrozole (2.5mg)Floracia Healthcare Pvt Ltdstrip of 5 tablets
Conizet 2.5mg TabletLetrozole (2.5mg)Novalab Healthcare Pvt Ltdstrip of 5 tablets
Culet 2.5mg TabletLetrozole (2.5mg)Cureill Pharma Pvt. Ltd.strip of 5 tablets
DavaIndia Letrozole 2.5mg TabletLetrozole (2.5mg)Davaindia Generic Pharmacystrip of 5 tablets
E-Ova L 2.5 TabletLetrozole (2.5mg)Koye Pharmaceuticals Pvt ltdstrip of 5 tablets

Showing 30 of 169 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Medicines for the same conditions

Letrozole is recorded in the NepalDoc medicine catalog for: Breast cancer.

For Breast cancer: Capecitabine, Epirubicin, Melphalan, Norethisterone, Paclitaxel, Tamoxifen.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.